![Frontiers | Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target? Frontiers | Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target?](https://www.frontiersin.org/files/Articles/730048/fphys-12-730048-HTML/image_m/fphys-12-730048-g002.jpg)
Frontiers | Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target?
![Frontiers | Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target? Frontiers | Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target?](https://www.frontiersin.org/files/Articles/730048/fphys-12-730048-HTML/image_m/fphys-12-730048-t002.jpg)
Frontiers | Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target?
![DOC) 2020 What happened after Eusebius? Chronicles and narrative identities in the fourth century, in R. Flower, M. Ludlow, eds., Rhetoric and religious identity in Late Antiquity, Oxford, Oxford University Press, 2020, DOC) 2020 What happened after Eusebius? Chronicles and narrative identities in the fourth century, in R. Flower, M. Ludlow, eds., Rhetoric and religious identity in Late Antiquity, Oxford, Oxford University Press, 2020,](https://0.academia-photos.com/attachment_thumbnails/65076814/mini_magick20201201-19947-cep190.png?1606822751)